Literature DB >> 23838009

Receptor-mediated Ca2+ and PKC signaling triggers the loss of cortical PKA compartmentalization through the redistribution of gravin.

Micah B Schott1, Bryon Grove.   

Abstract

A-Kinase Anchoring Proteins (AKAPs) direct the flow of cellular information by positioning multiprotein signaling complexes into proximity with effector proteins. However, certain AKAPs are not stationary but can undergo spatiotemporal redistribution in response to stimuli. Gravin, a 300kD AKAP that intersects with a diverse signaling array, is localized to the plasma membrane but has been shown to translocate to the cytosol following the elevation of intracellular calcium ([Ca(2+)]i). Despite the potential for gravin redistribution to impact multiple signaling pathways, the dynamics of this event remain poorly understood. In this study, quantitative microscopy of cells expressing gravin-EGFP revealed that Ca(2+) elevation caused the complete translocation of gravin from the cell cortex to the cytosol in as little as 60s of treatment with ionomycin or thapsigargin. In addition, receptor mediated signaling was also shown to cause gravin redistribution following ATP treatment, and this event required both [Ca(2+)]i elevation and PKC activation. To understand the mechanism for Ca(2+) mediated gravin dynamics, deletion of calmodulin-binding domains revealed that a fourth putative calmodulin binding domain called CB4 (a.a. 670-694) is critical for targeting gravin to the cell cortex despite its location downstream of gravin's membrane-targeting domains, which include an N-terminal myristoylation site and three polybasic domains. Finally, confocal microscopy of cells co-transfected with gravin-EYFP and PKA RII-ECFP revealed that gravin redistribution mediated by ionomycin, thapsigargin, and ATP each triggered the gravin-dependent loss of PKA localized at the cell cortex. Our results support the hypothesis that gravin redistribution regulates cross-talk between PKA-dependent signaling and receptor-mediated events involving Ca(2+) and PKC.
© 2013.

Entities:  

Keywords:  1,2-Bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid tetrakis(acetoxymethyl ester); A-Kinase Anchoring Protein; AKAP; AKAP12; ATP; BAPTA-AM; BIM; CB4; CaM; Calcium; ECFP; EGFP; EYFP; G protein coupled receptor; GPCR; Gravin; IM; InsP3; PB1–3; PDE4; PKA; PKC; PLC; Purinergic receptor; RII; SERCA; SES; SOCE; SSeCKS; Src-Suppressed C-Kinase Substrate; Tg; WT; [Ca(2+)](i); adenosine triphosphate; bisindolylmaleimide; calcium–calmodulin; calmodulin binding domain 4; enhanced cyan fluorescent protein; enhanced green fluorescent protein; enhanced yellow fluorescent protein; inositol triphosphate; intracellular calcium concentration; ionomycin; phosphodiesterase type 4; phospholipase C; polybasic domains 1 through 3; protein kinase A; protein kinase C; regulatory subunit of type II PKA; sarco/endoplasmic reticulum calcium ATPase; standard extracellular solution; store-operated calcium entry; thapsigargin; wild-type/full-length; β2-adrenergic receptor; β2AR

Mesh:

Substances:

Year:  2013        PMID: 23838009      PMCID: PMC3796772          DOI: 10.1016/j.cellsig.2013.07.004

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  38 in total

1.  The scaffold protein gravin (cAMP-dependent protein kinase-anchoring protein 250) binds the beta 2-adrenergic receptor via the receptor cytoplasmic Arg-329 to Leu-413 domain and provides a mobile scaffold during desensitization.

Authors:  G Fan ; E Shumay; H Wang ; C C Malbon
Journal:  J Biol Chem       Date:  2001-04-17       Impact factor: 5.157

2.  Differential and regulated binding of cAMP-dependent protein kinase and protein kinase C isoenzymes to gravin in human model neurons: Evidence that gravin provides a dynamic platform for the localization for kinases during neuronal development.

Authors:  Jörg Piontek; Roland Brandt
Journal:  J Biol Chem       Date:  2003-07-10       Impact factor: 5.157

Review 3.  Networking with AKAPs: context-dependent regulation of anchored enzymes.

Authors:  Emily J Welch; Brian W Jones; John D Scott
Journal:  Mol Interv       Date:  2010-04

4.  Gravin dynamics regulates the subcellular distribution of PKA.

Authors:  Xiaohong Yan; Magdalena Walkiewicz; Jennifer Carlson; Laura Leiphon; Bryon Grove
Journal:  Exp Cell Res       Date:  2009-01-13       Impact factor: 3.905

Review 5.  P2 receptors in health and disease.

Authors:  Gary A Weisman; Ningpu Yu; Zhongji Liao; Fernando Gonzaléz; Laurie Erb; Cheikh I Seye
Journal:  Biotechnol Genet Eng Rev       Date:  2006

6.  Calmodulin and cyclin D anchoring sites on the Src-suppressed C kinase substrate, SSeCKS.

Authors:  Xueying Lin; Irwin H Gelman
Journal:  Biochem Biophys Res Commun       Date:  2002-02-08       Impact factor: 3.575

7.  Intracellular distribution of gravin, a PKA and PKC binding protein, in vascular endothelial cells.

Authors:  B D Grove; A K Bruchey
Journal:  J Vasc Res       Date:  2001 Mar-Apr       Impact factor: 1.934

8.  AKAPs competing peptide HT31 disrupts the inhibitory effect of PKA on RhoA activity.

Authors:  Ying Wang; Yongchang Chen; Min Chen; Wenrong Xu
Journal:  Oncol Rep       Date:  2006-10       Impact factor: 3.906

9.  Gravin, an autoantigen recognized by serum from myasthenia gravis patients, is a kinase scaffold protein.

Authors:  J B Nauert; T M Klauck; L K Langeberg; J D Scott
Journal:  Curr Biol       Date:  1997-01-01       Impact factor: 10.834

10.  Involvement of the protein kinase C substrate, SSeCKS, in the actin-based stellate morphology of mesangial cells.

Authors:  P J Nelson; K Moissoglu; J Vargas; P E Klotman; I H Gelman
Journal:  J Cell Sci       Date:  1999-02       Impact factor: 5.285

View more
  8 in total

1.  The A-Kinase Anchoring Protein (AKAP) Glycogen Synthase Kinase 3β Interaction Protein (GSKIP) Regulates β-Catenin through Its Interactions with Both Protein Kinase A (PKA) and GSK3β.

Authors:  Alessandro Dema; Micha Friedemann Schröter; Ekaterina Perets; Philipp Skroblin; Marie Christine Moutty; Veronika Anita Deàk; Walter Birchmeier; Enno Klussmann
Journal:  J Biol Chem       Date:  2016-08-02       Impact factor: 5.157

Review 2.  Potential for therapeutic targeting of AKAP signaling complexes in nervous system disorders.

Authors:  Angela R Wild; Mark L Dell'Acqua
Journal:  Pharmacol Ther       Date:  2017-12-17       Impact factor: 12.310

Review 3.  A-kinase anchoring proteins: cAMP compartmentalization in neurodegenerative and obstructive pulmonary diseases.

Authors:  W J Poppinga; P Muñoz-Llancao; C González-Billault; M Schmidt
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

4.  FRET biosensors reveal AKAP-mediated shaping of subcellular PKA activity and a novel mode of Ca(2+)/PKA crosstalk.

Authors:  Micah B Schott; Faith Gonowolo; Benjamin Maliske; Bryon Grove
Journal:  Cell Signal       Date:  2016-01-07       Impact factor: 4.315

5.  Activity-dependent inhibitory gating in molecular signaling cascades induces a novel form of intermediate-term synaptic facilitation in Aplysia californica.

Authors:  Soren Fischbach; Ashley M Kopec; Thomas J Carew
Journal:  Learn Mem       Date:  2014-03-17       Impact factor: 2.460

6.  Perineurial Barrier Glia Physically Respond to Alcohol in an Akap200-Dependent Manner to Promote Tolerance.

Authors:  Sarah J Parkhurst; Pratik Adhikari; Jovana S Navarrete; Arièle Legendre; Miguel Manansala; Fred W Wolf
Journal:  Cell Rep       Date:  2018-02-13       Impact factor: 9.423

Review 7.  Cardiac function modulation depends on the A-kinase anchoring protein complex.

Authors:  Yan-Rong Zhu; Xiao-Xin Jiang; Yaguo Zheng; Jing Xiong; Dongping Wei; Dai-Min Zhang
Journal:  J Cell Mol Med       Date:  2019-09-11       Impact factor: 5.310

Review 8.  Exploring Morphine-Triggered PKC-Targets and Their Interaction with Signaling Pathways Leading to Pain via TrkA.

Authors:  Darlene A Pena; Mariana Lemos Duarte; Dimitrius T Pramio; Lakshmi A Devi; Deborah Schechtman
Journal:  Proteomes       Date:  2018-10-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.